Ignite Creation Date:
2025-12-24 @ 4:18 PM
Ignite Modification Date:
2025-12-25 @ 2:16 PM
Study NCT ID:
NCT02533466
Status:
COMPLETED
Last Update Posted:
2017-08-02
First Post:
2015-08-24
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
In Vivo Investigation of Initial Stages of Enamel Erosion
Sponsor:
GlaxoSmithKline
Organization:
Study Overview
Official Title:
Study to Investigate the Initial Stages of Enamel Erosion in Vivo
Status:
COMPLETED
Status Verified Date:
2017-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This exploratory study is designed to help develop a clinical model to measure the earlier stages of dietary acid medicated enamel loss. The study will use fluoride as positive control to explore the validity of this design.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: